1126 related articles for article (PubMed ID: 35405385)
1. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model.
Yadav PD; Mohandas S; Shete AM; Nyayanit DA; Gupta N; Patil DY; Sapkal GN; Potdar V; Kadam M; Kumar A; Kumar S; Suryavanshi D; Mote CS; Abraham P; Panda S; Bhargava B
Vector Borne Zoonotic Dis; 2022 May; 22(5):289-296. PubMed ID: 35580212
[No Abstract] [Full Text] [Related]
3. Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
Bricker TL; Joshi A; Soudani N; Scheaffer SM; Patel N; Guebre-Xabier M; Smith G; Diamond MS; Boon ACM
J Virol; 2024 Mar; 98(3):e0120623. PubMed ID: 38305154
[TBL] [Abstract][Full Text] [Related]
4. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
[TBL] [Abstract][Full Text] [Related]
5. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
[TBL] [Abstract][Full Text] [Related]
6. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.
Mohandas S; Yadav PD; Shete A; Nyayanit D; Jain R; Sapkal G; Mote C
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337002
[TBL] [Abstract][Full Text] [Related]
7. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
Case JB; Scheaffer SM; Darling TL; Bricker TL; Adams LJ; Harastani HH; Trende R; Sanapala S; Fremont DH; Boon ACM; Diamond MS
J Virol; 2023 Sep; 97(9):e0062823. PubMed ID: 37676002
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.
Lu L; Mok BWY; Chen LL; Chan JMC; Tsang OTY; Lam BHS; Chuang VWM; Chu AWH; Chan WM; Ip JD; Chan BPC; Zhang R; Yip CCY; Cheng VCC; Chan KH; Jin DY; Hung IFN; Yuen KY; Chen H; To KKW
Clin Infect Dis; 2022 Aug; 75(1):e822-e826. PubMed ID: 34915551
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters.
Uraki R; Kiso M; Imai M; Yamayoshi S; Ito M; Fujisaki S; Takashita E; Ujie M; Furusawa Y; Yasuhara A; Iwatsuki-Horimoto K; Sakai-Tagawa Y; Watanabe S; Hasegawa H; Kawaoka Y
Nat Microbiol; 2022 Aug; 7(8):1252-1258. PubMed ID: 35705860
[TBL] [Abstract][Full Text] [Related]
11. Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.
Yuan L; Zhu H; Chen P; Zhou M; Ma J; Liu X; Wu K; Chen R; Liu Q; Yu H; Li L; Wang J; Zhang Y; Ge S; Yuan Q; Tang Q; Cheng T; Guan Y; Xia N
Cell Mol Immunol; 2022 Dec; 19(12):1392-1399. PubMed ID: 36258005
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters.
Rissmann M; Noack D; van Riel D; Schmitz KS; de Vries RD; van Run P; Lamers MM; Geurts van Kessel CH; Koopmans MPG; Fouchier RAM; Kuiken T; Haagmans BL; Rockx B
Emerg Microbes Infect; 2022 Dec; 11(1):1778-1786. PubMed ID: 35787236
[TBL] [Abstract][Full Text] [Related]
13. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.
Yuan S; Ye ZW; Liang R; Tang K; Zhang AJ; Lu G; Ong CP; Man Poon VK; Chan CC; Mok BW; Qin Z; Xie Y; Chu AW; Chan WM; Ip JD; Sun H; Tsang JO; Yuen TT; Chik KK; Chan CC; Cai JP; Luo C; Lu L; Yip CC; Chu H; To KK; Chen H; Jin DY; Yuen KY; Chan JF
Science; 2022 Jul; 377(6604):428-433. PubMed ID: 35737809
[TBL] [Abstract][Full Text] [Related]
14. Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters.
McMahan K; Giffin V; Tostanoski LH; Chung B; Siamatu M; Suthar MS; Halfmann P; Kawaoka Y; Piedra-Mora C; Jain N; Ducat S; Kar S; Andersen H; Lewis MG; Martinot AJ; Barouch DH
Med; 2022 Apr; 3(4):262-268.e4. PubMed ID: 35313451
[TBL] [Abstract][Full Text] [Related]
15. The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
Abdelnabi R; Foo CS; Zhang X; Lemmens V; Maes P; Slechten B; Raymenants J; André E; Weynand B; Dallmeier K; Neyts J
Antiviral Res; 2022 Feb; 198():105253. PubMed ID: 35066015
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2.
Braun MR; Martinez CI; Dora EG; Showalter LJ; Mercedes AR; Tucker SN
Front Immunol; 2023; 14():1086035. PubMed ID: 36911687
[TBL] [Abstract][Full Text] [Related]
17. Transmission and re-infection of Omicron variant XBB.1.5 in hamsters.
Halfmann PJ; Uraki R; Kuroda M; Iwatsuki-Horimoto K; Yamayoshi S; Ito M; Kawaoka Y
EBioMedicine; 2023 Jul; 93():104677. PubMed ID: 37352827
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of vaccination and previous infection against the Omicron BA.1 variant in Syrian hamsters.
Halfmann PJ; Kuroda M; Maemura T; Chiba S; Armbrust T; Wright R; Balaram A; Florek KR; Bateman AC; Kawaoka Y
Cell Rep; 2022 Apr; 39(3):110688. PubMed ID: 35421378
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
Armando F; Beythien G; Kaiser FK; Allnoch L; Heydemann L; Rosiak M; Becker S; Gonzalez-Hernandez M; Lamers MM; Haagmans BL; Guilfoyle K; van Amerongen G; Ciurkiewicz M; Osterhaus ADME; Baumgärtner W
Nat Commun; 2022 Jun; 13(1):3519. PubMed ID: 35725735
[TBL] [Abstract][Full Text] [Related]
20. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
